nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—ADRA2A—type 2 diabetes mellitus	0.113	0.325	CbGaD
Mianserin—HTR2C—type 2 diabetes mellitus	0.104	0.299	CbGaD
Mianserin—CYP1A2—type 2 diabetes mellitus	0.0785	0.226	CbGaD
Mianserin—CYP3A4—type 2 diabetes mellitus	0.0519	0.15	CbGaD
Mianserin—HTR7—Bromocriptine—type 2 diabetes mellitus	0.037	0.0924	CbGbCtD
Mianserin—HTR6—Bromocriptine—type 2 diabetes mellitus	0.0325	0.081	CbGbCtD
Mianserin—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0296	0.0739	CbGbCtD
Mianserin—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.029	0.0723	CbGbCtD
Mianserin—DRD3—Bromocriptine—type 2 diabetes mellitus	0.0268	0.0668	CbGbCtD
Mianserin—ADRA2C—Bromocriptine—type 2 diabetes mellitus	0.0258	0.0643	CbGbCtD
Mianserin—ADRA2B—Bromocriptine—type 2 diabetes mellitus	0.0245	0.061	CbGbCtD
Mianserin—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0189	0.0471	CbGbCtD
Mianserin—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0178	0.0444	CbGbCtD
Mianserin—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.017	0.0424	CbGbCtD
Mianserin—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.017	0.0424	CbGbCtD
Mianserin—DRD2—Bromocriptine—type 2 diabetes mellitus	0.0157	0.0391	CbGbCtD
Mianserin—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00923	0.023	CbGbCtD
Mianserin—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00824	0.0205	CbGbCtD
Mianserin—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00813	0.0203	CbGbCtD
Mianserin—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00761	0.019	CbGbCtD
Mianserin—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00727	0.0181	CbGbCtD
Mianserin—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00725	0.0181	CbGbCtD
Mianserin—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00687	0.0171	CbGbCtD
Mianserin—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00663	0.0165	CbGbCtD
Mianserin—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00625	0.0156	CbGbCtD
Mianserin—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00599	0.0149	CbGbCtD
Mianserin—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00579	0.0144	CbGbCtD
Mianserin—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00524	0.0131	CbGbCtD
Mianserin—CYP1A2—Losartan—type 2 diabetes mellitus	0.00468	0.0117	CbGbCtD
Mianserin—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00397	0.0099	CbGbCtD
Mianserin—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00381	0.00949	CbGbCtD
Mianserin—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00381	0.00949	CbGbCtD
Mianserin—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0036	0.00898	CbGbCtD
Mianserin—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00268	0.00669	CbGbCtD
Mianserin—CYP3A4—Losartan—type 2 diabetes mellitus	0.00245	0.00612	CbGbCtD
Mianserin—SLC6A2—sympathetic nervous system—type 2 diabetes mellitus	0.00222	0.072	CbGeAlD
Mianserin—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00214	0.0694	CbGeAlD
Mianserin—HTR2A—arteriole—type 2 diabetes mellitus	0.00209	0.0679	CbGeAlD
Mianserin—SLC6A2—autonomic nervous system—type 2 diabetes mellitus	0.00149	0.0484	CbGeAlD
Mianserin—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00144	0.0466	CbGeAlD
Mianserin—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.00133	0.0433	CbGeAlD
Mianserin—SLC6A3—nerve—type 2 diabetes mellitus	0.00104	0.0337	CbGeAlD
Mianserin—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.00104	0.0337	CbGeAlD
Mianserin—HTR1D—artery—type 2 diabetes mellitus	0.00102	0.0332	CbGeAlD
Mianserin—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.000895	0.0291	CbGeAlD
Mianserin—SLC6A2—nerve—type 2 diabetes mellitus	0.000838	0.0272	CbGeAlD
Mianserin—HTR2A—hindlimb—type 2 diabetes mellitus	0.000828	0.0269	CbGeAlD
Mianserin—HTR7—artery—type 2 diabetes mellitus	0.000814	0.0264	CbGeAlD
Mianserin—HTR7—nerve—type 2 diabetes mellitus	0.000808	0.0262	CbGeAlD
Mianserin—DRD2—nerve—type 2 diabetes mellitus	0.000764	0.0248	CbGeAlD
Mianserin—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.00076	0.0247	CbGeAlD
Mianserin—HTR7—endothelium—type 2 diabetes mellitus	0.000688	0.0223	CbGeAlD
Mianserin—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.000646	0.021	CbGeAlD
Mianserin—HRH2—cardiovascular system—type 2 diabetes mellitus	0.000556	0.0181	CbGeAlD
Mianserin—HTR2A—artery—type 2 diabetes mellitus	0.000508	0.0165	CbGeAlD
Mianserin—HTR2A—nerve—type 2 diabetes mellitus	0.000504	0.0164	CbGeAlD
Mianserin—HTR2A—endothelium—type 2 diabetes mellitus	0.000429	0.0139	CbGeAlD
Mianserin—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000355	0.0115	CbGeAlD
Mianserin—HTR1D—kidney—type 2 diabetes mellitus	0.000348	0.0113	CbGeAlD
Mianserin—HRH2—liver—type 2 diabetes mellitus	0.000344	0.0112	CbGeAlD
Mianserin—HTR2B—cardiovascular system—type 2 diabetes mellitus	0.00033	0.0107	CbGeAlD
Mianserin—DRD2—retina—type 2 diabetes mellitus	0.000316	0.0103	CbGeAlD
Mianserin—HTR2B—cortex of kidney—type 2 diabetes mellitus	0.000315	0.0102	CbGeAlD
Mianserin—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000296	0.00962	CbGeAlD
Mianserin—HTR2B—adipose tissue—type 2 diabetes mellitus	0.000291	0.00947	CbGeAlD
Mianserin—ADRA2C—nephron tubule—type 2 diabetes mellitus	0.00029	0.00941	CbGeAlD
Mianserin—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000287	0.00932	CbGeAlD
Mianserin—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000283	0.00919	CbGeAlD
Mianserin—HTR7—kidney—type 2 diabetes mellitus	0.000277	0.00899	CbGeAlD
Mianserin—ADRA2C—kidney—type 2 diabetes mellitus	0.000254	0.00827	CbGeAlD
Mianserin—ADRA2C—pancreas—type 2 diabetes mellitus	0.000253	0.00821	CbGeAlD
Mianserin—ADRA2C—cortex of kidney—type 2 diabetes mellitus	0.000248	0.00805	CbGeAlD
Mianserin—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000241	0.00782	CbGeAlD
Mianserin—ADRA2C—adipose tissue—type 2 diabetes mellitus	0.000229	0.00745	CbGeAlD
Mianserin—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000216	0.00703	CbGeAlD
Mianserin—CYP2B6—kidney—type 2 diabetes mellitus	0.000212	0.00688	CbGeAlD
Mianserin—HTR2A—retina—type 2 diabetes mellitus	0.000209	0.00678	CbGeAlD
Mianserin—ADRA2A—pancreas—type 2 diabetes mellitus	0.000202	0.00655	CbGeAlD
Mianserin—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000198	0.00642	CbGeAlD
Mianserin—HRH1—adipose tissue—type 2 diabetes mellitus	0.000186	0.00605	CbGeAlD
Mianserin—Epinastine—ADRA2A—type 2 diabetes mellitus	0.000185	0.0669	CrCbGaD
Mianserin—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000183	0.00594	CbGeAlD
Mianserin—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000176	0.00573	CbGeAlD
Mianserin—HTR7—liver—type 2 diabetes mellitus	0.000175	0.00568	CbGeAlD
Mianserin—HTR2A—kidney—type 2 diabetes mellitus	0.000173	0.00561	CbGeAlD
Mianserin—Metixene—HTR2C—type 2 diabetes mellitus	0.000172	0.062	CrCbGaD
Mianserin—Angiopathy—Metformin—type 2 diabetes mellitus	0.000163	0.00133	CcSEcCtD
Mianserin—Pancytopenia—Ramipril—type 2 diabetes mellitus	0.000163	0.00133	CcSEcCtD
Mianserin—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000162	0.00132	CcSEcCtD
Mianserin—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000162	0.00132	CcSEcCtD
Mianserin—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000162	0.00132	CcSEcCtD
Mianserin—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000161	0.00131	CcSEcCtD
Mianserin—ADRA2C—liver—type 2 diabetes mellitus	0.000161	0.00522	CbGeAlD
Mianserin—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000161	0.00131	CcSEcCtD
Mianserin—Neutropenia—Ramipril—type 2 diabetes mellitus	0.00016	0.00131	CcSEcCtD
Mianserin—Hepatitis—Losartan—type 2 diabetes mellitus	0.00016	0.0013	CcSEcCtD
Mianserin—CYP3A4—kidney—type 2 diabetes mellitus	0.00016	0.00519	CbGeAlD
Mianserin—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.00016	0.0013	CcSEcCtD
Mianserin—Myalgia—Gliclazide—type 2 diabetes mellitus	0.00016	0.0013	CcSEcCtD
Mianserin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000159	0.0013	CcSEcCtD
Mianserin—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000159	0.0013	CcSEcCtD
Mianserin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000159	0.0013	CcSEcCtD
Mianserin—Hypotension—Glyburide—type 2 diabetes mellitus	0.000159	0.0013	CcSEcCtD
Mianserin—Asthenia—Glipizide—type 2 diabetes mellitus	0.000159	0.00129	CcSEcCtD
Mianserin—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000159	0.00129	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000158	0.00129	CcSEcCtD
Mianserin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000158	0.00129	CcSEcCtD
Mianserin—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.000158	0.00129	CcSEcCtD
Mianserin—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000158	0.00129	CcSEcCtD
Mianserin—CYP2D6—kidney—type 2 diabetes mellitus	0.000157	0.00511	CbGeAlD
Mianserin—Pruritus—Glipizide—type 2 diabetes mellitus	0.000157	0.00128	CcSEcCtD
Mianserin—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000156	0.00127	CcSEcCtD
Mianserin—Weight increased—Ramipril—type 2 diabetes mellitus	0.000156	0.00127	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000155	0.00126	CcSEcCtD
Mianserin—Vertigo—Valsartan—type 2 diabetes mellitus	0.000155	0.00126	CcSEcCtD
Mianserin—Syncope—Valsartan—type 2 diabetes mellitus	0.000154	0.00126	CcSEcCtD
Mianserin—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000154	0.00126	CcSEcCtD
Mianserin—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000154	0.00126	CcSEcCtD
Mianserin—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000154	0.00125	CcSEcCtD
Mianserin—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000153	0.00125	CcSEcCtD
Mianserin—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000153	0.00125	CcSEcCtD
Mianserin—Vertigo—Orlistat—type 2 diabetes mellitus	0.000153	0.00125	CcSEcCtD
Mianserin—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000152	0.00124	CcSEcCtD
Mianserin—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000151	0.00123	CcSEcCtD
Mianserin—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.00015	0.00122	CcSEcCtD
Mianserin—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.00015	0.00122	CcSEcCtD
Mianserin—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000149	0.00122	CcSEcCtD
Mianserin—Tinnitus—Losartan—type 2 diabetes mellitus	0.000149	0.00122	CcSEcCtD
Mianserin—Jaundice—Ramipril—type 2 diabetes mellitus	0.000149	0.00121	CcSEcCtD
Mianserin—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000149	0.00121	CcSEcCtD
Mianserin—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000148	0.00121	CcSEcCtD
Mianserin—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000148	0.0012	CcSEcCtD
Mianserin—Convulsion—Orlistat—type 2 diabetes mellitus	0.000147	0.0012	CcSEcCtD
Mianserin—Azatadine—CYP3A4—type 2 diabetes mellitus	0.000147	0.0532	CrCbGaD
Mianserin—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000147	0.0012	CcSEcCtD
Mianserin—Tremor—Metformin—type 2 diabetes mellitus	0.000147	0.0012	CcSEcCtD
Mianserin—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000147	0.00119	CcSEcCtD
Mianserin—Myalgia—Valsartan—type 2 diabetes mellitus	0.000147	0.00119	CcSEcCtD
Mianserin—Dizziness—Glipizide—type 2 diabetes mellitus	0.000146	0.00119	CcSEcCtD
Mianserin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000146	0.00119	CcSEcCtD
Mianserin—Mirtazapine—ADRA2A—type 2 diabetes mellitus	0.000146	0.0527	CrCbGaD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000146	0.00119	CcSEcCtD
Mianserin—Angiopathy—Losartan—type 2 diabetes mellitus	0.000145	0.00118	CcSEcCtD
Mianserin—Myalgia—Orlistat—type 2 diabetes mellitus	0.000145	0.00118	CcSEcCtD
Mianserin—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000145	0.00118	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000144	0.00117	CcSEcCtD
Mianserin—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000143	0.00117	CcSEcCtD
Mianserin—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000143	0.00116	CcSEcCtD
Mianserin—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000143	0.00116	CcSEcCtD
Mianserin—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000142	0.00115	CcSEcCtD
Mianserin—Syncope—Metformin—type 2 diabetes mellitus	0.000141	0.00115	CcSEcCtD
Mianserin—Oedema—Valsartan—type 2 diabetes mellitus	0.000141	0.00115	CcSEcCtD
Mianserin—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00014	0.00114	CcSEcCtD
Mianserin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00014	0.00114	CcSEcCtD
Mianserin—Rash—Glipizide—type 2 diabetes mellitus	0.00014	0.00114	CcSEcCtD
Mianserin—CYP1A2—liver—type 2 diabetes mellitus	0.00014	0.00453	CbGeAlD
Mianserin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000139	0.00114	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000139	0.00114	CcSEcCtD
Mianserin—Oedema—Orlistat—type 2 diabetes mellitus	0.000139	0.00113	CcSEcCtD
Mianserin—Headache—Glipizide—type 2 diabetes mellitus	0.000139	0.00113	CcSEcCtD
Mianserin—Tremor—Irbesartan—type 2 diabetes mellitus	0.000139	0.00113	CcSEcCtD
Mianserin—Shock—Valsartan—type 2 diabetes mellitus	0.000138	0.00113	CcSEcCtD
Mianserin—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000138	0.00112	CcSEcCtD
Mianserin—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000138	0.00112	CcSEcCtD
Mianserin—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000138	0.00112	CcSEcCtD
Mianserin—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000137	0.00112	CcSEcCtD
Mianserin—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000137	0.00112	CcSEcCtD
Mianserin—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000137	0.00111	CcSEcCtD
Mianserin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000137	0.00111	CcSEcCtD
Mianserin—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000137	0.00111	CcSEcCtD
Mianserin—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000136	0.00111	CcSEcCtD
Mianserin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000136	0.00111	CcSEcCtD
Mianserin—Agitation—Irbesartan—type 2 diabetes mellitus	0.000136	0.00111	CcSEcCtD
Mianserin—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000136	0.00111	CcSEcCtD
Mianserin—Hypertension—Metformin—type 2 diabetes mellitus	0.000135	0.0011	CcSEcCtD
Mianserin—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000135	0.0011	CcSEcCtD
Mianserin—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000135	0.0011	CcSEcCtD
Mianserin—Mirtazapine—HTR2C—type 2 diabetes mellitus	0.000134	0.0485	CrCbGaD
Mianserin—CYP2B6—liver—type 2 diabetes mellitus	0.000134	0.00435	CbGeAlD
Mianserin—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000134	0.00109	CcSEcCtD
Mianserin—Myalgia—Metformin—type 2 diabetes mellitus	0.000134	0.00109	CcSEcCtD
Mianserin—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000133	0.00108	CcSEcCtD
Mianserin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000133	0.00108	CcSEcCtD
Mianserin—Syncope—Irbesartan—type 2 diabetes mellitus	0.000133	0.00108	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000133	0.00108	CcSEcCtD
Mianserin—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000132	0.00108	CcSEcCtD
Mianserin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000132	0.00108	CcSEcCtD
Mianserin—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000132	0.00107	CcSEcCtD
Mianserin—Hypotension—Valsartan—type 2 diabetes mellitus	0.000131	0.00107	CcSEcCtD
Mianserin—Constipation—Gliclazide—type 2 diabetes mellitus	0.000131	0.00107	CcSEcCtD
Mianserin—Tremor—Losartan—type 2 diabetes mellitus	0.00013	0.00106	CcSEcCtD
Mianserin—Cyproheptadine—HTR2C—type 2 diabetes mellitus	0.00013	0.047	CrCbGaD
Mianserin—Rash—Glimepiride—type 2 diabetes mellitus	0.00013	0.00106	CcSEcCtD
Mianserin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00013	0.00106	CcSEcCtD
Mianserin—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.00013	0.00106	CcSEcCtD
Mianserin—Rash—Sitagliptin—type 2 diabetes mellitus	0.00013	0.00106	CcSEcCtD
Mianserin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00013	0.00106	CcSEcCtD
Mianserin—Headache—Glimepiride—type 2 diabetes mellitus	0.000129	0.00105	CcSEcCtD
Mianserin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000129	0.00105	CcSEcCtD
Mianserin—Anaemia—Losartan—type 2 diabetes mellitus	0.000129	0.00105	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000128	0.00104	CcSEcCtD
Mianserin—Agitation—Losartan—type 2 diabetes mellitus	0.000128	0.00104	CcSEcCtD
Mianserin—Oedema—Metformin—type 2 diabetes mellitus	0.000128	0.00104	CcSEcCtD
Mianserin—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000128	0.00104	CcSEcCtD
Mianserin—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000128	0.00104	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000127	0.00103	CcSEcCtD
Mianserin—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000126	0.00103	CcSEcCtD
Mianserin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000126	0.00103	CcSEcCtD
Mianserin—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000126	0.00103	CcSEcCtD
Mianserin—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000126	0.00103	CcSEcCtD
Mianserin—Shock—Metformin—type 2 diabetes mellitus	0.000126	0.00103	CcSEcCtD
Mianserin—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000126	0.00102	CcSEcCtD
Mianserin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000125	0.00102	CcSEcCtD
Mianserin—Vertigo—Losartan—type 2 diabetes mellitus	0.000125	0.00102	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000125	0.00102	CcSEcCtD
Mianserin—Somnolence—Valsartan—type 2 diabetes mellitus	0.000125	0.00102	CcSEcCtD
Mianserin—Syncope—Losartan—type 2 diabetes mellitus	0.000125	0.00102	CcSEcCtD
Mianserin—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000125	0.00102	CcSEcCtD
Mianserin—Leukopenia—Losartan—type 2 diabetes mellitus	0.000125	0.00102	CcSEcCtD
Mianserin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000124	0.00101	CcSEcCtD
Mianserin—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000124	0.00101	CcSEcCtD
Mianserin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000123	0.001	CcSEcCtD
Mianserin—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000123	0.001	CcSEcCtD
Mianserin—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000122	0.000997	CcSEcCtD
Mianserin—Asthenia—Glyburide—type 2 diabetes mellitus	0.000122	0.000996	CcSEcCtD
Mianserin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000121	0.000989	CcSEcCtD
Mianserin—Fatigue—Valsartan—type 2 diabetes mellitus	0.000121	0.000987	CcSEcCtD
Mianserin—Oedema—Irbesartan—type 2 diabetes mellitus	0.000121	0.000984	CcSEcCtD
Mianserin—Pruritus—Glyburide—type 2 diabetes mellitus	0.000121	0.000982	CcSEcCtD
Mianserin—Mental disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.000979	CcSEcCtD
Mianserin—Constipation—Valsartan—type 2 diabetes mellitus	0.00012	0.000979	CcSEcCtD
Mianserin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.00012	0.000977	CcSEcCtD
Mianserin—Fatigue—Orlistat—type 2 diabetes mellitus	0.00012	0.000976	CcSEcCtD
Mianserin—Hypotension—Metformin—type 2 diabetes mellitus	0.00012	0.000975	CcSEcCtD
Mianserin—Shock—Irbesartan—type 2 diabetes mellitus	0.000119	0.000968	CcSEcCtD
Mianserin—Arthralgia—Losartan—type 2 diabetes mellitus	0.000119	0.000966	CcSEcCtD
Mianserin—Myalgia—Losartan—type 2 diabetes mellitus	0.000119	0.000966	CcSEcCtD
Mianserin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000118	0.000965	CcSEcCtD
Mianserin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000118	0.000964	CcSEcCtD
Mianserin—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000118	0.000961	CcSEcCtD
Mianserin—Rash—Bromocriptine—type 2 diabetes mellitus	0.000118	0.000957	CcSEcCtD
Mianserin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000957	CcSEcCtD
Mianserin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000117	0.000956	CcSEcCtD
Mianserin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000117	0.000951	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000117	0.00095	CcSEcCtD
Mianserin—Dry mouth—Losartan—type 2 diabetes mellitus	0.000116	0.000945	CcSEcCtD
Mianserin—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000115	0.000936	CcSEcCtD
Mianserin—Confusional state—Losartan—type 2 diabetes mellitus	0.000115	0.000934	CcSEcCtD
Mianserin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000114	0.000933	CcSEcCtD
Mianserin—Somnolence—Metformin—type 2 diabetes mellitus	0.000114	0.000927	CcSEcCtD
Mianserin—Oedema—Losartan—type 2 diabetes mellitus	0.000114	0.000926	CcSEcCtD
Mianserin—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000113	0.00092	CcSEcCtD
Mianserin—Tremor—Ramipril—type 2 diabetes mellitus	0.000112	0.000912	CcSEcCtD
Mianserin—Shock—Losartan—type 2 diabetes mellitus	0.000112	0.000911	CcSEcCtD
Mianserin—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000111	0.000908	CcSEcCtD
Mianserin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000111	0.000907	CcSEcCtD
Mianserin—Tachycardia—Losartan—type 2 diabetes mellitus	0.000111	0.000904	CcSEcCtD
Mianserin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.00011	0.0009	CcSEcCtD
Mianserin—Fatigue—Metformin—type 2 diabetes mellitus	0.00011	0.000899	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.00011	0.000897	CcSEcCtD
Mianserin—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00011	0.000894	CcSEcCtD
Mianserin—Agitation—Ramipril—type 2 diabetes mellitus	0.00011	0.000894	CcSEcCtD
Mianserin—Constipation—Metformin—type 2 diabetes mellitus	0.000109	0.000892	CcSEcCtD
Mianserin—Prochlorperazine—HTR2C—type 2 diabetes mellitus	0.000109	0.0394	CrCbGaD
Mianserin—HTR2A—liver—type 2 diabetes mellitus	0.000109	0.00354	CbGeAlD
Mianserin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000108	0.000884	CcSEcCtD
Mianserin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000108	0.000882	CcSEcCtD
Mianserin—Rash—Glyburide—type 2 diabetes mellitus	0.000107	0.000875	CcSEcCtD
Mianserin—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000107	0.000875	CcSEcCtD
Mianserin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000107	0.000874	CcSEcCtD
Mianserin—Vertigo—Ramipril—type 2 diabetes mellitus	0.000107	0.000874	CcSEcCtD
Mianserin—Syncope—Ramipril—type 2 diabetes mellitus	0.000107	0.000873	CcSEcCtD
Mianserin—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000107	0.000871	CcSEcCtD
Mianserin—Headache—Glyburide—type 2 diabetes mellitus	0.000107	0.00087	CcSEcCtD
Mianserin—Hypotension—Losartan—type 2 diabetes mellitus	0.000106	0.000866	CcSEcCtD
Mianserin—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000105	0.000859	CcSEcCtD
Mianserin—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000105	0.000855	CcSEcCtD
Mianserin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000104	0.00085	CcSEcCtD
Mianserin—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000104	0.000849	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000104	0.000844	CcSEcCtD
Mianserin—Convulsion—Ramipril—type 2 diabetes mellitus	0.000103	0.000843	CcSEcCtD
Mianserin—Constipation—Irbesartan—type 2 diabetes mellitus	0.000103	0.000842	CcSEcCtD
Mianserin—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000102	0.000832	CcSEcCtD
Mianserin—Myalgia—Ramipril—type 2 diabetes mellitus	0.000102	0.000828	CcSEcCtD
Mianserin—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000102	0.000828	CcSEcCtD
Mianserin—Mirtazapine—CYP1A2—type 2 diabetes mellitus	0.000101	0.0366	CrCbGaD
Mianserin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000101	0.000824	CcSEcCtD
Mianserin—Somnolence—Losartan—type 2 diabetes mellitus	0.000101	0.000823	CcSEcCtD
Mianserin—CYP3A4—liver—type 2 diabetes mellitus	0.000101	0.00328	CbGeAlD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000101	0.000823	CcSEcCtD
Mianserin—Asthenia—Valsartan—type 2 diabetes mellitus	0.000101	0.000822	CcSEcCtD
Mianserin—Asthenia—Orlistat—type 2 diabetes mellitus	9.96e-05	0.000812	CcSEcCtD
Mianserin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.95e-05	0.000811	CcSEcCtD
Mianserin—Pruritus—Valsartan—type 2 diabetes mellitus	9.94e-05	0.00081	CcSEcCtD
Mianserin—Dry mouth—Ramipril—type 2 diabetes mellitus	9.94e-05	0.00081	CcSEcCtD
Mianserin—CYP2D6—liver—type 2 diabetes mellitus	9.94e-05	0.00323	CbGeAlD
Mianserin—Confusional state—Ramipril—type 2 diabetes mellitus	9.83e-05	0.000801	CcSEcCtD
Mianserin—Pruritus—Orlistat—type 2 diabetes mellitus	9.83e-05	0.000801	CcSEcCtD
Mianserin—Fatigue—Losartan—type 2 diabetes mellitus	9.8e-05	0.000799	CcSEcCtD
Mianserin—Oedema—Ramipril—type 2 diabetes mellitus	9.75e-05	0.000794	CcSEcCtD
Mianserin—Constipation—Losartan—type 2 diabetes mellitus	9.72e-05	0.000792	CcSEcCtD
Mianserin—Rash—Gliclazide—type 2 diabetes mellitus	9.65e-05	0.000786	CcSEcCtD
Mianserin—Dermatitis—Gliclazide—type 2 diabetes mellitus	9.64e-05	0.000785	CcSEcCtD
Mianserin—Shock—Ramipril—type 2 diabetes mellitus	9.59e-05	0.000781	CcSEcCtD
Mianserin—Headache—Gliclazide—type 2 diabetes mellitus	9.58e-05	0.000781	CcSEcCtD
Mianserin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.56e-05	0.000779	CcSEcCtD
Mianserin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	9.54e-05	0.000778	CcSEcCtD
Mianserin—Tachycardia—Ramipril—type 2 diabetes mellitus	9.51e-05	0.000775	CcSEcCtD
Mianserin—Skin disorder—Ramipril—type 2 diabetes mellitus	9.47e-05	0.000771	CcSEcCtD
Mianserin—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.37e-05	0.000763	CcSEcCtD
Mianserin—Dizziness—Valsartan—type 2 diabetes mellitus	9.29e-05	0.000757	CcSEcCtD
Mianserin—Dizziness—Orlistat—type 2 diabetes mellitus	9.18e-05	0.000748	CcSEcCtD
Mianserin—Asthenia—Metformin—type 2 diabetes mellitus	9.18e-05	0.000748	CcSEcCtD
Mianserin—Hypotension—Ramipril—type 2 diabetes mellitus	9.11e-05	0.000742	CcSEcCtD
Mianserin—Pruritus—Metformin—type 2 diabetes mellitus	9.06e-05	0.000738	CcSEcCtD
Mianserin—Trimipramine—ADRA2A—type 2 diabetes mellitus	9.03e-05	0.0326	CrCbGaD
Mianserin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	8.88e-05	0.000724	CcSEcCtD
Mianserin—Rash—Valsartan—type 2 diabetes mellitus	8.86e-05	0.000722	CcSEcCtD
Mianserin—Dermatitis—Valsartan—type 2 diabetes mellitus	8.85e-05	0.000721	CcSEcCtD
Mianserin—Nortriptyline—HTR2C—type 2 diabetes mellitus	8.83e-05	0.0318	CrCbGaD
Mianserin—Headache—Valsartan—type 2 diabetes mellitus	8.8e-05	0.000717	CcSEcCtD
Mianserin—Rash—Orlistat—type 2 diabetes mellitus	8.76e-05	0.000714	CcSEcCtD
Mianserin—Paraesthesia—Ramipril—type 2 diabetes mellitus	8.75e-05	0.000713	CcSEcCtD
Mianserin—Dermatitis—Orlistat—type 2 diabetes mellitus	8.75e-05	0.000713	CcSEcCtD
Mianserin—Headache—Orlistat—type 2 diabetes mellitus	8.7e-05	0.000709	CcSEcCtD
Mianserin—Asthenia—Irbesartan—type 2 diabetes mellitus	8.67e-05	0.000706	CcSEcCtD
Mianserin—Somnolence—Ramipril—type 2 diabetes mellitus	8.66e-05	0.000706	CcSEcCtD
Mianserin—Pruritus—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000696	CcSEcCtD
Mianserin—Epinastine—CYP3A4—type 2 diabetes mellitus	8.52e-05	0.0308	CrCbGaD
Mianserin—Dizziness—Metformin—type 2 diabetes mellitus	8.46e-05	0.00069	CcSEcCtD
Mianserin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.41e-05	0.000686	CcSEcCtD
Mianserin—Fatigue—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000685	CcSEcCtD
Mianserin—Constipation—Ramipril—type 2 diabetes mellitus	8.33e-05	0.000679	CcSEcCtD
Mianserin—Trimipramine—HTR2C—type 2 diabetes mellitus	8.31e-05	0.03	CrCbGaD
Mianserin—Asthenia—Losartan—type 2 diabetes mellitus	8.16e-05	0.000665	CcSEcCtD
Mianserin—Rash—Metformin—type 2 diabetes mellitus	8.07e-05	0.000658	CcSEcCtD
Mianserin—Dermatitis—Metformin—type 2 diabetes mellitus	8.06e-05	0.000657	CcSEcCtD
Mianserin—Pruritus—Losartan—type 2 diabetes mellitus	8.04e-05	0.000655	CcSEcCtD
Mianserin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	8.03e-05	0.000654	CcSEcCtD
Mianserin—Mequitazine—CYP3A4—type 2 diabetes mellitus	8.02e-05	0.029	CrCbGaD
Mianserin—Headache—Metformin—type 2 diabetes mellitus	8.02e-05	0.000653	CcSEcCtD
Mianserin—Dizziness—Irbesartan—type 2 diabetes mellitus	7.99e-05	0.000651	CcSEcCtD
Mianserin—Oxcarbazepine—CYP3A4—type 2 diabetes mellitus	7.85e-05	0.0283	CrCbGaD
Mianserin—Rash—Irbesartan—type 2 diabetes mellitus	7.62e-05	0.000621	CcSEcCtD
Mianserin—Dermatitis—Irbesartan—type 2 diabetes mellitus	7.61e-05	0.00062	CcSEcCtD
Mianserin—Headache—Irbesartan—type 2 diabetes mellitus	7.57e-05	0.000617	CcSEcCtD
Mianserin—Dizziness—Losartan—type 2 diabetes mellitus	7.52e-05	0.000612	CcSEcCtD
Mianserin—Desipramine—HTR2C—type 2 diabetes mellitus	7.27e-05	0.0262	CrCbGaD
Mianserin—Rash—Losartan—type 2 diabetes mellitus	7.17e-05	0.000584	CcSEcCtD
Mianserin—Dermatitis—Losartan—type 2 diabetes mellitus	7.16e-05	0.000583	CcSEcCtD
Mianserin—Headache—Losartan—type 2 diabetes mellitus	7.12e-05	0.00058	CcSEcCtD
Mianserin—Nortriptyline—CYP2E1—type 2 diabetes mellitus	7e-05	0.0253	CrCbGaD
Mianserin—Asthenia—Ramipril—type 2 diabetes mellitus	6.99e-05	0.00057	CcSEcCtD
Mianserin—Pruritus—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000562	CcSEcCtD
Mianserin—Oxcarbazepine—ALB—type 2 diabetes mellitus	6.85e-05	0.0247	CrCbGaD
Mianserin—Mirtazapine—CYP3A4—type 2 diabetes mellitus	6.71e-05	0.0242	CrCbGaD
Mianserin—Nortriptyline—CYP1A2—type 2 diabetes mellitus	6.66e-05	0.024	CrCbGaD
Mianserin—Amitriptyline—ADRA2A—type 2 diabetes mellitus	6.65e-05	0.024	CrCbGaD
Mianserin—Dizziness—Ramipril—type 2 diabetes mellitus	6.45e-05	0.000525	CcSEcCtD
Mianserin—Imipramine—HTR2C—type 2 diabetes mellitus	6.16e-05	0.0222	CrCbGaD
Mianserin—Rash—Ramipril—type 2 diabetes mellitus	6.15e-05	0.000501	CcSEcCtD
Mianserin—Dermatitis—Ramipril—type 2 diabetes mellitus	6.14e-05	0.0005	CcSEcCtD
Mianserin—Amitriptyline—HTR2C—type 2 diabetes mellitus	6.12e-05	0.0221	CrCbGaD
Mianserin—Headache—Ramipril—type 2 diabetes mellitus	6.11e-05	0.000498	CcSEcCtD
Mianserin—Desipramine—CYP2E1—type 2 diabetes mellitus	5.76e-05	0.0208	CrCbGaD
Mianserin—Desipramine—CYP1A2—type 2 diabetes mellitus	5.48e-05	0.0198	CrCbGaD
Mianserin—Prochlorperazine—CYP3A4—type 2 diabetes mellitus	5.45e-05	0.0197	CrCbGaD
Mianserin—Imipramine—CYP2E1—type 2 diabetes mellitus	4.89e-05	0.0176	CrCbGaD
Mianserin—Amitriptyline—CYP2E1—type 2 diabetes mellitus	4.86e-05	0.0175	CrCbGaD
Mianserin—Imipramine—CYP1A2—type 2 diabetes mellitus	4.65e-05	0.0168	CrCbGaD
Mianserin—Amitriptyline—CYP1A2—type 2 diabetes mellitus	4.62e-05	0.0167	CrCbGaD
Mianserin—Nortriptyline—CYP3A4—type 2 diabetes mellitus	4.41e-05	0.0159	CrCbGaD
Mianserin—Trimipramine—CYP3A4—type 2 diabetes mellitus	4.15e-05	0.015	CrCbGaD
Mianserin—Nortriptyline—ALB—type 2 diabetes mellitus	3.85e-05	0.0139	CrCbGaD
Mianserin—Desipramine—CYP3A4—type 2 diabetes mellitus	3.63e-05	0.0131	CrCbGaD
Mianserin—Imipramine—CYP3A4—type 2 diabetes mellitus	3.08e-05	0.0111	CrCbGaD
Mianserin—Amitriptyline—CYP3A4—type 2 diabetes mellitus	3.06e-05	0.011	CrCbGaD
Mianserin—Amitriptyline—ALB—type 2 diabetes mellitus	2.67e-05	0.00963	CrCbGaD
Mianserin—HTR1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.61e-06	1.69e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.61e-06	1.69e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.61e-06	1.69e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.6e-06	1.68e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.59e-06	1.67e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.59e-06	1.67e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.59e-06	1.67e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.59e-06	1.67e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.59e-06	1.67e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.59e-06	1.66e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.58e-06	1.66e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.58e-06	1.66e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.57e-06	1.65e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	1.57e-06	1.65e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	1.57e-06	1.65e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.56e-06	1.64e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.56e-06	1.64e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.56e-06	1.64e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.56e-06	1.64e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.56e-06	1.64e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.55e-06	1.62e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	1.54e-06	1.61e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.54e-06	1.61e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.54e-06	1.61e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.54e-06	1.61e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.53e-06	1.6e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.52e-06	1.6e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.52e-06	1.6e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—RELA—type 2 diabetes mellitus	1.52e-06	1.6e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.52e-06	1.6e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.51e-06	1.59e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.51e-06	1.59e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.51e-06	1.59e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.51e-06	1.58e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.51e-06	1.58e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.51e-06	1.58e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	1.5e-06	1.57e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.49e-06	1.56e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.49e-06	1.56e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.49e-06	1.56e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.49e-06	1.56e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.49e-06	1.56e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.48e-06	1.56e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.48e-06	1.56e-05	CbGpPWpGaD
Mianserin—ADRA2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.48e-06	1.55e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.48e-06	1.55e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.47e-06	1.54e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	1.47e-06	1.54e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.47e-06	1.54e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.47e-06	1.54e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.47e-06	1.54e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.47e-06	1.54e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.47e-06	1.54e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.46e-06	1.54e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.46e-06	1.53e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.46e-06	1.53e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.46e-06	1.53e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.45e-06	1.52e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.45e-06	1.52e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.45e-06	1.52e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.44e-06	1.52e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.44e-06	1.51e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.44e-06	1.51e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.44e-06	1.51e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.44e-06	1.51e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.44e-06	1.51e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.44e-06	1.51e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	1.43e-06	1.51e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.43e-06	1.5e-05	CbGpPWpGaD
Mianserin—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.43e-06	1.5e-05	CbGpPWpGaD
Mianserin—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.42e-06	1.49e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.42e-06	1.49e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—SRC—type 2 diabetes mellitus	1.42e-06	1.49e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.41e-06	1.48e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.41e-06	1.48e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.41e-06	1.48e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.41e-06	1.48e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.41e-06	1.47e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.4e-06	1.47e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.39e-06	1.46e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.39e-06	1.46e-05	CbGpPWpGaD
Mianserin—ADRA2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.38e-06	1.45e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.38e-06	1.45e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.38e-06	1.45e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.38e-06	1.45e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.37e-06	1.44e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.37e-06	1.44e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.37e-06	1.44e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.37e-06	1.44e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.36e-06	1.43e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.36e-06	1.43e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.36e-06	1.43e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.36e-06	1.42e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.36e-06	1.42e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.36e-06	1.42e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.35e-06	1.42e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.35e-06	1.42e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.35e-06	1.42e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.35e-06	1.42e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.35e-06	1.41e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.35e-06	1.41e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	1.35e-06	1.41e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.34e-06	1.41e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.33e-06	1.4e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.33e-06	1.4e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.32e-06	1.39e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.32e-06	1.38e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.31e-06	1.38e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.31e-06	1.38e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.31e-06	1.37e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.3e-06	1.36e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.3e-06	1.36e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.29e-06	1.36e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.29e-06	1.36e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.28e-06	1.35e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.28e-06	1.34e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.27e-06	1.33e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.26e-06	1.32e-05	CbGpPWpGaD
Mianserin—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.26e-06	1.32e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.25e-06	1.31e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.24e-06	1.31e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.24e-06	1.3e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.24e-06	1.3e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.24e-06	1.3e-05	CbGpPWpGaD
Mianserin—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.24e-06	1.3e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.23e-06	1.3e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.23e-06	1.3e-05	CbGpPWpGaD
Mianserin—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.23e-06	1.29e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.23e-06	1.29e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.22e-06	1.28e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.22e-06	1.28e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.22e-06	1.28e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.22e-06	1.28e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.21e-06	1.27e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.2e-06	1.26e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.2e-06	1.26e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—SRC—type 2 diabetes mellitus	1.19e-06	1.25e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.19e-06	1.25e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.18e-06	1.24e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.18e-06	1.23e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.17e-06	1.23e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.17e-06	1.23e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.17e-06	1.22e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.16e-06	1.22e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.16e-06	1.22e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.16e-06	1.22e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.16e-06	1.22e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.16e-06	1.21e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.16e-06	1.21e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.15e-06	1.21e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.15e-06	1.2e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.14e-06	1.2e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.14e-06	1.2e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.14e-06	1.2e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.14e-06	1.2e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.14e-06	1.2e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.14e-06	1.2e-05	CbGpPWpGaD
Mianserin—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.12e-06	1.18e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—type 2 diabetes mellitus	1.12e-06	1.18e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	1.12e-06	1.18e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.12e-06	1.18e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.12e-06	1.18e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.12e-06	1.17e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	1.12e-06	1.17e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.11e-06	1.17e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.11e-06	1.17e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.11e-06	1.16e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.1e-06	1.16e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.1e-06	1.15e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.08e-06	1.14e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.08e-06	1.14e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.08e-06	1.14e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.08e-06	1.13e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.07e-06	1.12e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.07e-06	1.12e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.07e-06	1.12e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.06e-06	1.12e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.06e-06	1.12e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.06e-06	1.11e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.05e-06	1.1e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.05e-06	1.1e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.05e-06	1.1e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.04e-06	1.09e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.04e-06	1.09e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.04e-06	1.09e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.04e-06	1.09e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.04e-06	1.09e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.04e-06	1.09e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.04e-06	1.09e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.03e-06	1.08e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.03e-06	1.08e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.02e-06	1.07e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.02e-06	1.07e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.02e-06	1.07e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.01e-06	1.06e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.01e-06	1.06e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	9.99e-07	1.05e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	9.88e-07	1.04e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	9.7e-07	1.02e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.69e-07	1.02e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	9.58e-07	1.01e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—type 2 diabetes mellitus	9.54e-07	1e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.54e-07	1e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.51e-07	9.98e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.5e-07	9.97e-06	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.46e-07	9.93e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.45e-07	9.92e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	9.4e-07	9.86e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	9.35e-07	9.81e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.35e-07	9.81e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.33e-07	9.79e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	9.11e-07	9.55e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	9.05e-07	9.5e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	8.95e-07	9.39e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	8.92e-07	9.36e-06	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—AKT1—type 2 diabetes mellitus	8.88e-07	9.32e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	8.82e-07	9.25e-06	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.8e-07	9.24e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.67e-07	9.1e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	8.66e-07	9.09e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	8.66e-07	9.09e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—type 2 diabetes mellitus	8.62e-07	9.04e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.51e-07	8.92e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	8.32e-07	8.73e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	8.27e-07	8.68e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—type 2 diabetes mellitus	8.05e-07	8.44e-06	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.95e-07	8.34e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	7.92e-07	8.31e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	7.77e-07	8.15e-06	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.67e-07	8.05e-06	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.63e-07	8.01e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	7.62e-07	8e-06	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.42e-07	7.79e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.3e-07	7.66e-06	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	7.21e-07	7.57e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.19e-07	7.54e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.17e-07	7.52e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	6.99e-07	7.33e-06	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	6.76e-07	7.09e-06	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.74e-07	7.07e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	6.68e-07	7.01e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	6.68e-07	7.01e-06	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.63e-07	6.95e-06	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.61e-07	6.94e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	6.54e-07	6.86e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	6.11e-07	6.41e-06	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.03e-07	6.33e-06	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.7e-07	4.93e-06	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.98e-07	4.18e-06	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	3.07e-07	3.22e-06	CbGpPWpGaD
